ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 253 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,478,184 | +15.9% | 15,211 | -8.1% | 0.00% | 0.0% |
| Q2 2023 | $6,453,929 | +98.6% | 16,560 | +89.8% | 0.00% | +200.0% |
| Q1 2023 | $3,250,015 | -18.5% | 8,723 | -17.2% | 0.00% | -50.0% |
| Q4 2022 | $3,989,838 | -20.8% | 10,532 | -26.2% | 0.00% | 0.0% |
| Q3 2022 | $5,036,000 | -27.6% | 14,264 | -22.4% | 0.00% | -33.3% |
| Q2 2022 | $6,960,000 | +131.8% | 18,371 | +92.9% | 0.00% | +200.0% |
| Q1 2022 | $3,003,000 | +118.7% | 9,524 | -13.4% | 0.00% | 0.0% |
| Q1 2019 | $1,373,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |